Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.

Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A.

J Clin Invest. 1993 Jan;91(1):368-74.

2.

Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.

Kawasaki E, Yano M, Abiru N, Akazawa S, Nagataki S.

Diabetes Res Clin Pract. 1996 Apr;32(1-2):61-9.

PMID:
8803483
3.

Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).

Yano M, Moriuchi R, Kawasaki E, Watanabe M, Saito K, Takino H, Akazawa S, Miyamoto T, Nagataki S.

J Autoimmun. 1995 Feb;8(1):83-96.

PMID:
7734039
4.

Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Belgian Diabetes Registry.

Semakula C, Vandewalle CL, Van Schravendijk CF, Sodoyez JC, Schuit FC, Foriers A, Falorni A, Craen M, Decraene P, Pipeleers DG, Gorus FK.

Pancreas. 1996 May;12(4):321-33.

PMID:
8740397
5.

Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.

Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.

Diabetologia. 2002 Jan;45(1):66-76.

PMID:
11845225
6.

Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.

Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moody A, Grubin CE, Rowe R, Petersen J, McEvoy R, Lernmark A.

Diabetes. 1993 Apr;42(4):631-6.

PMID:
8454115
7.

Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.

Pediatr Diabetes. 2005 Dec;6(4):184-92.

PMID:
16390386
8.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
9.

Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.

Singh AK, Bhatia E, Dabadghao P, Bhatia V, Gellert SA, Colman PG.

Diabet Med. 2000 Apr;17(4):275-80.

PMID:
10821293
10.

Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.

Winnock F, Christie MR, Batstra MR, Aanstoot HJ, Weets I, Decochez K, Jopart P, Nicolaij D, Gorus FK; Belgian Diabetes Registry.

Diabetes Care. 2001 Jul;24(7):1181-6.

PMID:
11423499
11.

Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?

Shtauvere-Brameus A, Falorni A, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:259-62.

PMID:
12021119
12.

Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus.

Petersen JS, Kyvik KO, Bingley PJ, Gale EA, Green A, Dyrberg T, Beck-Nielsen H.

BMJ. 1997 May 31;314(7094):1575-9.

13.

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.

Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR.

Diabetes. 1993 Feb;42(2):359-62.

PMID:
8425674
14.

Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.

Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RD.

Diabetes. 1997 Aug;46(8):1270-5.

PMID:
9231650
16.

Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetes.

Kohnert KD, Hehmke B, Keilacker H, Ziegler M, Emmrich F, Laube F, Michaelis D.

Int J Clin Lab Res. 1996;26(1):55-9.

PMID:
8739857
17.

Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.

Marshall MO, Høyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Bottazzo GF.

J Autoimmun. 1994 Aug;7(4):497-508.

PMID:
7980851
18.

[GAD antibody in IDDM].

Yokota I, Shima K.

Rinsho Byori. 1998 Apr;46(4):331-7. Review. Japanese.

PMID:
9594623
19.

Islet cell autoimmunity in youth onset diabetes mellitus in Northern India.

Goswami R, Kochupillai N, Gupta N, Kukreja A, Lan M, Maclaren NK.

Diabetes Res Clin Pract. 2001 Jul;53(1):47-54.

PMID:
11378213
20.

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK.

Diabetes Care. 2000 Jun;23(6):838-44.

Supplemental Content

Support Center